Skip to main content
Log in

Drug Interactions of Clinical Importance

An Updated Guide

  • Special Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wagner K, Phillip T, Heinemeyer HH, et al. Interaction of cyclosporin and calcium antagonists. Transplant Proc 1989; 21: 1453–6

    PubMed  CAS  Google Scholar 

  2. Sahloul MZ, al-Kiek R, Ivanovich P, et al. Nonsteroidal anti-inflammatory drugs and antihypertensives. Nephron 1990; 56: 345–52

    Article  PubMed  CAS  Google Scholar 

  3. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 112: 289–300

    Google Scholar 

  4. Honig PK, Woolsley RL, Zamani K, et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992; 52: 231–8

    Article  PubMed  CAS  Google Scholar 

  5. Creutzfeldt W. Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders. Drug Saf 1994; 10: 66–82

    Article  PubMed  CAS  Google Scholar 

  6. Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 1994; 47: 1469–79

    Article  PubMed  CAS  Google Scholar 

  7. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13

    PubMed  CAS  Google Scholar 

  8. Dursun SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine and carbamezepine [letter]. Lancet 1993; 342: 442

    Article  PubMed  CAS  Google Scholar 

  9. Muly EC, McDonald W, Steffens D, et al. Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry 1993; 150: 1565

    PubMed  CAS  Google Scholar 

  10. Price LH, Heninger MD. Lithium in the treatment of mood disorders. N Engl J Med 1994; 331: 591–8

    Article  PubMed  CAS  Google Scholar 

  11. Livingston MG. Interactions with selective MAOIs. Lancet 1995; 345: 533–4

    Article  PubMed  CAS  Google Scholar 

  12. Neuvonen PJ, Pohjola-Sintonen S, Tacke U, et al. Five fatal cases of serotonin syndrome after moclobemide-citalopram and moclobemide-clomipramine overdoses. Lancet 1993; 342: 1419

    Article  PubMed  CAS  Google Scholar 

  13. Lefebvre H, Noblet C, Moore N, et al. Pseudophaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline. Clin Endocrinol 1995; 42: 92–9

    Article  Google Scholar 

Further Reading

  • Hansten PD, Horn JR. Drug interactions and updates, 8th ed. Vancouver: Applied Therapeutics, 1993

    Google Scholar 

  • Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9: 51–9

    Article  PubMed  CAS  Google Scholar 

  • Mclnnes GT, Brodie MJ. Drug interactions that matter: a critical appraisal. Drugs 1988; 36: 83–110

    Article  Google Scholar 

  • Reactions® Weekly and CD-ROM Database. Auckland: Adis International

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quinn, D.I., Day, R.O. Drug Interactions of Clinical Importance. Drug-Safety 12, 393–452 (1995). https://doi.org/10.2165/00002018-199512060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199512060-00005

Keywords

Navigation